-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TAtH8PXoJ6gcohzCEOVrRVmn7r831EzsUNTGmK/qJQJZ9gkEcEyamB4Y77lY9gmg uSIoaySJ+E4g47ggaMkxdg== 0000890163-08-000529.txt : 20080714 0000890163-08-000529.hdr.sgml : 20080714 20080714184451 ACCESSION NUMBER: 0000890163-08-000529 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080708 FILED AS OF DATE: 20080714 DATE AS OF CHANGE: 20080714 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PIPEX PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000894158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133808303 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: 734-332-7800 MAIL ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC DATE OF NAME CHANGE: 19970730 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 19940606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stergis Nicholas CENTRAL INDEX KEY: 0001380826 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12584 FILM NUMBER: 08951600 BUSINESS ADDRESS: BUSINESS PHONE: 212-243-5800 MAIL ADDRESS: STREET 1: 1804 BRICKELL AVENUE STREET 2: 9TH FLOOR CITY: MIAMI STATE: FL ZIP: 33131 4 1 s11-8623_ex.xml X0303 4 2008-07-08 0 0000894158 PIPEX PHARMACEUTICALS, INC. PP 0001380826 Stergis Nicholas C/O PIPEX PHARMACEUTICALS, INC 3930 VARSITY DRIVE ANN ARBOR MI 48108 1 1 0 0 Chief Executive Officer Stock Options .72 2008-07-08 4 A 0 800000 0 A 2018-07-07 Common Stock 800000 800000 D One quarter vests on date of grant. The remainder will vest quarterly in equal increments over the next three years. These options will also vest in full should the Issuer be acquired. /s/ Nicholas Stergis 2008-07-14 -----END PRIVACY-ENHANCED MESSAGE-----